Status:

COMPLETED

Basic Research Study to Examine the Relation Between Muscle Insulin Resistance and Lipid Production in the Liver.

Lead Sponsor:

Yale University

Collaborating Sponsors:

National Institute on Aging (NIA)

Conditions:

Insulin Resistance

Eligibility:

All Genders

18-90 years

Phase:

NA

Brief Summary

The purpose of this study was to examine the pathophysiology of insulin resistance and the relation to the metabolic syndrome in humans.

Detailed Description

In this study insulin resistant (IR), young offspring of parents with type 2 diabetes (18-46 years) and healthy, lean elderly individuals (65-90 years) underwent 1H/13C MRS measurements of liver and m...

Eligibility Criteria

Inclusion

  • Body Mass Index \< 29 kg/m2
  • No regular exercise routine
  • Non-smokers
  • Absence of systemic and organ disease.

Exclusion

  • Hematocrit \< 35 vol%
  • History of claustrophobia
  • Ferromagnetic implants
  • Regular exercise regimen
  • Not weight stable
  • Any significant hematological, neurological, musculoskeletal or endocrine disease (including diabetes mellitus)
  • Any significant cardiovascular condition, including confirmed CAD and prior cardiovascular events
  • Taking coumadin as anticoagulant therapy.

Key Trial Info

Start Date :

January 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 30 2012

Estimated Enrollment :

41 Patients enrolled

Trial Details

Trial ID

NCT02196051

Start Date

January 1 2008

End Date

January 30 2012

Last Update

August 15 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

YCCI/YNNH Hospital Research Unit

New Haven, Connecticut, United States, 06520